Global Registration Trial of Efficacy and Safety of CTL019 in Pediatric and Young Adult Patients with Relapsed/Refractory (R/R) Acute Lymphoblastic Leukemia (ALL): Update to the Interim Analysis


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Buechner, J; Grupp, SA; Maude, SL; Boyer, M; Bittencourt, H; Laetsch, TW; Bader, P; Verneris, MR; Stefanski, H; Myers, GD; Qayed, M; Pulsipher, MA; De Moerloose, B; Hiramatsu, H; Schlis, K; Davis, K; Martin, PL; Nemecek, E; Peters, C; Wood, P; Taran, T; Mueller, KT; Zhang, Y; Rives, S

Published Date

  • September 2017

Published In

Volume / Issue

  • 17 /

Start / End Page

  • S263 - S264

Published By

International Standard Serial Number (ISSN)

  • 2152-2650

Digital Object Identifier (DOI)

  • 10.1016/j.clml.2017.07.030